Dublin, June 12, 2023 (GLOBE NEWSWIRE) -- The "Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The global market for cold chain products in plasma fractionation is estimated to grow significantly. By 2027, it is projected to reach a value of USD 711 million, showing a compound annual growth rate (CAGR) of 4.5% during the forecast period, starting from USD 569 million in 2022.
The expansion of the cold chain products market is driven by various factors, including increasing concerns regarding zoonotic diseases, growing utilization of immunoglobulins and other plasma products in diverse therapeutic areas, and a rising demand for plasma-derived medicinal products.
The industry for cold chain products is expected to progress due to the increasing need for plasma freezers and other cold chain products, as well as the adoption of advanced cold storage devices. These advancements in technology contribute to the overall growth and development of the cold chain products sector.
Ultra-low temperature freezer segment was dominated by the highest share in Cold Chain Products Market for Plasma Fractionation
The Ultra-low temperature freezer segment accounted for the highest share of the global Cold Chain Products for Plasma Fractionation in 2021. Increasing Demand for Plasma-Derived Medicinal Products, Advancements in Plasma Fractionation Technologies, and Growing Need for Cold Chain Infrastructure all some of the factors that are anticipated to promote market expansion throughout the projected period.
Blood collection centers and blood component providers accounted for the fastest growing segment of the Cold Chain Products Market for Plasma Fractionation in 2021.
In 2021, Blood collection centers and blood component providers held the highest market share for cold chain products for plasma fractionation. Growing demand for plasma fractionation, rising awareness and screening for blood-borne diseases, and expansion of healthcare infrastructure are some of the factors that contribute to the big proportion of this market.
Latin America is expected to witness the fastest growth in the forecast period.
In the forecast period, Latin America in the Cold Chain Products Market for Plasma Fractionation will have the fastest rising regional growth. Large number of hospitals and healthcare facilities, increasing spread of chronic diseases such as immune deficiencies, hemophilia, and autoimmune disorders are the main factors driving market growth.
The rise of these illnesses in Latin America has resulted in a higher requirement for plasma freezers and refrigerators to preserve vital medical resources. In response to growing healthcare needs, advancements in medical treatments, and a growing understanding of the advantages of plasma-based products, the plasma fractionation sector in Latin America has been expanding.
This expansion drives the need for suitable storage devices, such as plasma freezers and refrigerators.
Competitive landscape
Key players in the cold chain products market are B Medical Systems (US), Thermo Fisher Scientific (US), Haier Biomedical (China), and Eppendorf SE (Germany).
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 186 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value (USD) in 2022 | $569 Million |
| Forecasted Market Value (USD) by 2027 | $711 Million |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Rising Use of Immunoglobulins and Other Plasma Products in a Range of Therapeutic Area
- Increasing Demand for Plasma-Derived Medicinal Products
- Technological Advancements in Refrigeration Equipment and Systems
Opportunities
- Demand for Plasma Fractionation Centre
- Government Support for Cold Chain Infrastructure Development
Challenges
- Shortage of Trained Manpower & Limited Resources to Maintain the Equipments
- Stringent Government Regulations
- Environmental Concerns Regarding Greenhouse Gas Emissions
Key Players
- B Medical Systems
- Blue Star Limited
- Thermo Fisher Scientific
- Godrej and Boyce Manufacturing Co. Ltd.
- Haeir Biomedical
- Eppendorf Se
- Avantor, Inc.
- Biolife Solutions Inc.
- Helmer Scientific Inc
- Vestfrost Solutions
- Jeio Tech Inc.
- Deepee Cooling Products Pvt. Ltd.
- Berlinger & Co. AG
- Monnit Corporation
- Zhejiang Heli Refrigeration Equipment Co. Ltd.
Other Players
- Qingdao Carebios Biological Technology Co.Ltd.
- Ebac Co. Ltd.
- Biotecno
- Zhongke Meiling Cryogenics Co. Ltd.
- Bionics Scientific Technologies (P) Ltd.
- Stericox India Private Limited
- Enviro Technologies
- Withnell Sensors
- Tecnosoft Srl
- Philipp Kirsch GmbH
Pricing Analysis
- Average Selling Prices of Key Players, by Type
- Average Selling Price Trends
Supply Chain Analysis
- Ecosystem/Market Map
Patent Analysis
- Patent Publication Trends for Market
Key Technologies
- Complementary Technologies
- Adjacent Technologies
Regulatory Landscape
- Regulatory Analysis
- Regulatory Bodies, Government Agencies, and Other Organization
For more information about this report visit https://www.researchandmarkets.com/r/ey439a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
